Related Experiment Videos
Several different ion channel modulators abrogate contact hypersensitivity in mice
J J Wille1, A Kydonieus, R S Kalish
1ConvaTec, Division of Bristol-Myers Squibb Company, Princeton, NJ, USA. JJWille@aol.com
Skin Pharmacology and Applied Skin Physiology
|May 15, 1999
Summary
Ion channel modulators effectively suppress skin sensitization reactions in mice. This finding suggests potential applications for improving transdermal drug delivery by reducing allergic contact dermatitis.
Area of Science:
- Pharmacology
- Immunology
- Dermatology
Background:
- Transdermal drug delivery faces challenges due to adverse skin sensitization reactions.
- Contact hypersensitivity is a significant concern for topical medications.
Purpose of the Study:
- To investigate the efficacy of ion channel modulators in suppressing contact hypersensitivity.
- To evaluate the potential of these modulators in facilitating transdermal drug delivery.
Main Methods:
- Mice were sensitized to contact sensitizers like dinitrochlorobenzene (DNCB) and nadolol.
- Topical pretreatment with ion channel modulators (amiloride, ethacrynic acid, nifedipine, verapamil) was applied.
- Contact hypersensitivity reactions (CHR) were assessed.
Main Results:
- Amiloride, ethacrynic acid, nifedipine, and verapamil demonstrated suppression of contact hypersensitivity.
- All tested ion channel modulators, including combinations, abrogated the induction of CHR.
- Nadolol-induced sensitization was also suppressed by verapamil and nifedipine.
Conclusions:
- Ion channel inhibitors are broadly effective in inhibiting allergic contact dermatitis.
- These findings support the use of ion channel modulators to enhance transdermal drug delivery of sensitizing agents.